Skip to Main Content

Chapter 73: Acute Kidney Injury

INTRODUCTION

  • Acute kidney injury (AKI) is a clinical syndrome generally defined by an abrupt reduction in kidney functions as evidenced by changes in serum creatinine (Scr), blood urea nitrogen (BUN), and urine output.

  • RIFLE (Risk, Injury, Failure, Loss of Kidney Function, and End-Stage Renal Disease), AKIN (Acute Kidney Injury Network), and the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guidelines are three criteria-based classification systems developed to define and stage AKI in different patient populations (Table 73–1).

  • All three staging systems have been validated across different patient populations and their staging correlates closely with hospital mortality, cost, and length of stay.

  • Scr and urine output are the main diagnostic criteria for each staging system.

TABLE 73–1abcRIFLE, AKIN, and KDIGO Classification Schemes for Acute Kidney Injurya
View Table||Download (.pdf)
TABLE 73–1 RIFLE, AKIN, and KDIGO Classification Schemes for Acute Kidney Injurya
RIFLE Category Scr and GFRb Criteria Urine Output Criteria
Risk Scr increase to 1.5-fold or GFR decrease >25% from baseline <0.5 mL/kg/h for ≥6 hours
Injury Scr increase to twofold or GFR decrease >50% from baseline <0.5 mL/kg/h for ≥12 hours
Failure Scr increase to threefold or GFR decrease >75% from baseline, or Scr ≥4 mg/dL (≥354 μmol/L) with an acute increase of at least 0.5 mg/dL (44 μmol/L) Anuria for ≥12 hours
Loss Complete loss of function (RRT) for >4 weeks
ESKD RRT >3 months
AKIN Criteria Scr Criteria Urine Output Criteria
Stage 1 Scr increase ≥0.3 mg/dL (≥27 μmol/L) or 1.5- to 2-fold from baseline <0.5 mL/kg/h for ≥6 hours
Stage 2 Scr increase >2- to 3-fold from baseline <0.5 mL/kg/h for ≥12 hours
Stage 3 Scr increase >3-fold from baseline, or Scr ≥4 mg/dL (≥354 μmol/L) with an acute increase of at least 0.5 mg/dL (≥44 μmol/L), or need for RRT <0.3 mL/kg/h for ≥24 hours or anuria for ≥12 hours
KDIGO Criteria Scr Criteria Urine Output Criteria
Stage 1 Scr increase ≥0.3 mg/dL (≥27 μmol/L) or 1.5–1.9 times from baseline <0.5 mL/kg/h for 6–12 hours
Stage 2 Scr increase 2–2.9 times from baseline <0.5 mL/kg/h for ≥12 hours
Stage 3 Scr increase three times from baseline, or Scr ≥4 mg/dL (≥354 μmol/L), or need for RRT, or eGFRc <35 mL/min/1.73 m2 (<0.34 mL/s/m2) in patients <18 years Anuria for ≥12 hours

(AKIN, Acute Kidney Injury Network; ESKD, end-stage kidney disease; eGFR, estimated glomerular filtration rate; h, hours; KDIGO, Kidney Disease: Improving Global Outcomes; RIFLE, Risk, Injury, Failure, Loss of Kidney Function, and End-Stage Kidney Disease; RRT, renal replacement therapy; Scr, serum creatinine.)

a

For all staging systems, the criterion that leads to worst possible diagnosis should be used.

b

GFR calculated using the Modification of Diet in Renal Disease (MDRD) equation.

c

GFR calculated using ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

This site uses cookies to provide, maintain and improve your experience. MHE Privacy Center Close